SFI
LMAT icon

Susquehanna Fundamental Investments’s LeMaitre Vascular LMAT Stock Holding History

Susquehanna Fundamental Investments’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,809
Closed -$351K – 1161
2024
Q4 		$351K Buy
+3,809
New +$366K 0.01% 913
2024
Q2 		$317K Sell
3,847
-1,457
-27% -$107K 0.01% 782
2024
Q1 		$352K Buy
+5,304
New +$327K 0.02% 521

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Susquehanna Fundamental Investments's LMAT Position: Q1 2025 in Review

Susquehanna Fundamental Investments sold out of LeMaitre Vascular (LMAT) in Q1 2025, closing a stake of 3,809 shares — an estimated $351K sold.

Susquehanna Fundamental Investments first reported a position in LMAT in Q1 2024 and held it in 3 quarters. The position peaked at $352K in Q1 2024. 288 funds tracked by Wall St. Rank hold LMAT as of Q1 2025.

  • Susquehanna Fundamental Investments reported no remaining LeMaitre Vascular position as of Q1 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 3,809 LeMaitre Vascular shares in Q1 2025, an estimated $351K.
  • Susquehanna Fundamental Investments first reported a position in LeMaitre Vascular in Q1 2024 and held it in 3 quarters.
  • Susquehanna Fundamental Investments's LeMaitre Vascular position peaked at $352K in Q1 2024.
  • 288 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2025, filed 14 May 2025.